Florida Jury Finds No Infringement by J&J of Rembrandt’s Contact Lens Patent

August 29, 2017 — On August 29, 2017, a jury at the United States District Court for the Middle District of Florida, Jacksonville Division, found that Johnson & Johnson Vision Care, Inc.’s Acuvue Oasys® contact lenses do not literally infringe Rembrandt Vision Technologies L.P.’s (Rembrandt) patent.  This repeats a 2012 jury verdict of non-infringement that the Federal Circuit vacated for a new trial after determining that Rembrandt had been prejudiced by false expert testimony and withheld information.

The patent-at-issue is U.S. Patent Number 5,712,327, entitled “Soft Gas Permeable Contact Lens Having Improved Clinical Performance.”  The case is captioned: Rembrandt Vision Technologies LP v. Johnson & Johnson Vision Care Inc., 3-11-cv-00819.

By: Chika Seidel